An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination
收藏官方服务:
资源简介:
Carreno et al. collected human serum samples for the NDV-HXP-S vaccine clinical trial (phase 1) and performed secondary analysis to determine antibody characteristics according to each cohort.
提供机构:
ImmPort创建时间:
2024-01-25



